ConductScience.org, home

Paper39201463

Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies.

Kim HJ and 1 other. Int J Mol Sci, 2024. Cited by 66 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies. Papers, record 39201463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201463

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
14.71, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim HJHyun Jeehttps://orcid.org/0000-0001-8552-9744
2Kim YHYeong Hohttps://orcid.org/0000-0003-4983-4906

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
KeloidMajor topic
Humans
Animals
Signal Transduction
Extracellular Matrix
Transforming Growth Factor beta
Wound Healing

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07836569Outcomes of the A.S.A.P. Algorithm for Keloids: A Controlled Prospective StudyBackground

Source ClinicalTrials.gov

Download CSV of trials

References268

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126301129Surgical Excision with Adjuvant Irradiation for Treatment of Keloid Scars: A Systematic Review.Plast Reconstr Surg Glob Open2015https://conductscience.org/library/papers/26301129PubMed
226829033IL-6 Polymorphism and Susceptibility to Keloid Formation in a Japanese Population.J Invest Dermatol2016https://conductscience.org/library/papers/26829033PubMed
318371435Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.Cell Stem Cell2008https://conductscience.org/library/papers/18371435PubMed
417024100Functional implications of the IL-6 signaling pathway in keloid pathogenesis.J Invest Dermatol2007https://conductscience.org/library/papers/17024100PubMed
522954589Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.FASEB J2012https://conductscience.org/library/papers/22954589PubMed
620711176A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population.Nat Genet2010https://conductscience.org/library/papers/20711176PubMed
727506499Keloidectomy with core fillet flap and intralesional verapamil injection for recurrent earlobe keloids.Indian J Dermatol Venereol Leprol2016https://conductscience.org/library/papers/27506499PubMed
84877599Fluocinolone acetonide 0.2 per cent cream--a co-operative clinical trial.Br J Dermatol1968https://conductscience.org/library/papers/4877599PubMed
924478874Hypopigmentation and subcutaneous fat, muscle atrophy after local corticosteroid injection.Korean J Anesthesiol2013https://conductscience.org/library/papers/24478874PubMed
1032205184Overexpression of miR-133a-3p inhibits fibrosis and proliferation of keloid fibroblasts by regulating IRF5 to inhibit the TGF-β/Smad2 pathway.Mol Cell Probes2020https://conductscience.org/library/papers/32205184PubMed
1120725565Innovative therapies in the treatment of keloids and hypertrophic scars.J Clin Aesthet Dermatol2010https://conductscience.org/library/papers/20725565PubMed
1212560674Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels.Plast Reconstr Surg2003https://conductscience.org/library/papers/12560674PubMed
1322272655A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision.Dermatol Surg2012https://conductscience.org/library/papers/22272655PubMed
1426911400Verapamil is Less Effective than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial.Acta Derm Venereol2016https://conductscience.org/library/papers/26911400PubMed
1532537319Keloids: Which Types Can Be Excised without Risk of Recurrence? A New Clinical Classification.Plast Reconstr Surg Glob Open2020https://conductscience.org/library/papers/32537319PubMed
1634357011Adjuvant Radiotherapy after Surgical Excision in Keloids.Medicina (Kaunas)2021https://conductscience.org/library/papers/34357011PubMed
173470308Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.J Clin Invest1987https://conductscience.org/library/papers/3470308PubMed
1823249157Pulsed dye laser for the treatment of keloid and hypertrophic scars: a systematic review.Expert Rev Med Devices2012https://conductscience.org/library/papers/23249157PubMed
19345427Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results.Scand J Plast Reconstr Surg1977https://conductscience.org/library/papers/345427PubMed
2031961041Correlation between serum IL 37 levels with keloid severity.J Cosmet Dermatol2020https://conductscience.org/library/papers/31961041PubMed

See all 268 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42908757Deciphering fibroblast and myeloid-cell states in keloids: an integrative analysis identifies ANKRD1 as a ferroptosis-related candidate gene.Front Immunol2026https://conductscience.org/library/papers/42908757PubMed
42818600HUCMSCs-Derived Exosomes Attenuate Keloid Fibroblast Pathological Phenotypes with Associated Metabolic-Redox-Matrix Network Remodeling: A Proteomic and In Vivo Study.Balkan Med J2026https://conductscience.org/library/papers/42818600PubMed
42799479Identification and Preliminary mRNA Validation of Key Genes Associated with Tolerogenic Dendritic Cells in Keloid Based on Transcriptome Data.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/42799479PubMed
42792159Mitochondrial Transplantation Suppresses mtDNA-cGAS/STING-Mediated Innate Immunity by Enhancing PINK1/Parkin-Dependent Mitophagy to Attenuate Keloid Fibrosis.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792159PubMed
42787495Endothelial system dysregulation underlies keloid development and therapeutic targeting.Front Cell Dev Biol2026https://conductscience.org/library/papers/42787495PubMed
42770101A novel CAVIN1/GAS5 axis suppresses skin fibrosis through mitochondrial fission-mediated attenuation of the TGF-β/Smad pathway.Burns Trauma2026https://conductscience.org/library/papers/42770101PubMed
42688921Mechanistic insights into Strontium-90 superficial radiotherapy in keloids: senescence-associated changes and ECM remodeling across cell-matrix scales.Front Pharmacol2026https://conductscience.org/library/papers/42688921PubMed
42665390Gene Expression of TGF-β1, Matrix Metalloproteinases, and Collagen in Keloid Patients and Their Growth Patterns in 2D and 3D Cell Cultures: An In Vitro Study.In Vivo2026https://conductscience.org/library/papers/42665390PubMed
42657113Hydrogel microneedles functioning in pathological surroundings: where soft materials overcome hard scars.Mater Today Bio2026https://conductscience.org/library/papers/42657113PubMed
42436808Mitochondria-targeted phototherapeutic system enabling spatiotemporal-controlled NADH depletion for keloid intervention.Mater Today Bio2026https://conductscience.org/library/papers/42436808PubMed
42306298Extracellular vesicle-mediated cell-cell communication in keloids and hypertrophic scars: mechanisms, methodological caveats, and therapeutic perspectives.Front Cell Dev Biol2026https://conductscience.org/library/papers/42306298PubMed
42305783Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars.Burns Trauma2026https://conductscience.org/library/papers/42305783PubMed
42212370Epigenetic orchestration of scar formation: Therapeutic potential of targeting DNA methylation and non‑coding RNAs in cutaneous fibrosis (Review).Mol Med Rep2026https://conductscience.org/library/papers/42212370PubMed
42195168Surgical Excision with Adjuvant Therapies in the Management of Keloids: A Systematic Review.Medicina (Kaunas)2026https://conductscience.org/library/papers/42195168PubMed
42168421Effect of Granulocyte Colony-Stimulating Factor (G-CSF) and Botulinum Toxin Type A on Fat Graft Retention in a Rat Model.Aesthetic Plast Surg2026https://conductscience.org/library/papers/42168421PubMed
42138176POSTN(+) fibroblasts and SPP1(+) macrophages in scar formation: A review of mechanisms and therapeutic targets (Review).Mol Med Rep2026https://conductscience.org/library/papers/42138176PubMed
42121883Refractory Keloids and Hypertrophic Scars: Immune Dysregulation and Neuroimmune Mechanisms Underlying Treatment Failure.Cells2026https://conductscience.org/library/papers/42121883PubMed
42112383Advances in the interplay between mechanical forces and inflammatory immunity in keloid formation.Front Immunol2026https://conductscience.org/library/papers/42112383PubMed
42098529Research advances in the pathogenesis and photodynamic therapy of pathological scars.Lasers Med Sci2026https://conductscience.org/library/papers/42098529PubMed
42074238Exploring the Complexities of TGF-β Signaling in Keloids: Beyond the Classical Smad Pathway.Int J Mol Sci2026https://conductscience.org/library/papers/42074238PubMed

See all 49 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39201463

GET https://conductscience.org/api/papers/v1/39201463/references?page=2